2025 91st National Pharmaceutical Trade Fair (PHARMCHINA)

The 2025 91st National Pharmaceutical Trade Fair (PHARMCHINA) aims to be a service trade and information exchange platform for domestic pharmaceuticals, health products, and related technologies. It serves as an important venue for cooperation and learning within the industry. This year, the fair promotes the concept of "Pharmaceutical Technology Creates a Healthy Future" and collaborates with the entire industry to drive the Chinese pharmaceutical sector toward a comprehensive sustainable development path characterized by innovation-driven growth and expansion, dedicated to contributing to the happiness and well-being of the people.

The fair will feature 4,000 standard booths, engage 2,000 health enterprises, and showcase over 100,000 product varieties. Additionally, it will host 150 special meetings and facilitate 300 business matchmaking sessions, covering a broad range of displayed items such as pharmaceutical raw materials, packaging, and manufacturing equipment. Previously, the PHARMCHINA event was held concurrently with API China and NHNE, collectively occupying 170,000 square meters and attracting nearly 4,000 renowned domestic and international companies from over 20 countries, with more than 200,000 attendees engaging in exchanges.

Multiple themed exhibition areas will highlight the event, including the Brand (Special Decoration) Area, Chemical Drugs Area, OTC Area, Traditional Chinese Medicine and Ethnic Medicines Area, Chinese Herbal Pieces and Herbal Materials Area, Chinese Medicine Health Preservation Area, Pharmaceutical Distribution Equipment and Technology Area, Biotechnology and Innovation Area, Internet + Pharmaceutical Area, as well as the High-end Health Tea Area. The featured products will include antibiotics, cardiovascular medicine, traditional Chinese medicine, functional tea drinks, and more, demonstrating the achievements of pharmaceutical innovation.

In November 2025, the Nanjing Pharmaceutical Trade Fair will once again gather both new and old friends from the industry, jointly witnessing the vitality and developmental opportunities of the sector. Let us look forward to working together to promote high-quality development in the pharmaceutical industry and sketch a new blueprint for the sector!